Please assess the completion status of the following clinical trial:

Trial Title: Corneal Neurotization as a Treatment for Neurotrophic Keratopathy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with neurotrophic cornea~Exclusion Criteria:~* Patients with history of penetrating keratoplasty

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Corneal neurotization (Type: EXPERIMENTAL): Patients will undergo the corneal neurotization as described in the protocol. Their pre and post-procedure corneal sensation will be measured as a primary outcome measure. Secondary outcome measures will include visual acuity, corneal opacity, NEI VFQ, and confocal microscopy.

Based on this trial design, predict the completion outcome and termination type (if applicable).